Series A · AI & Machine Learning · Valencia, Spain · Founded 2012 · 51–200 employees
Quibim is a pioneering medtech company that develops AI-powered imaging biomarkers for precision medicine, transforming medical images like MRI, CT, and PET scans into quantitative data for more accurate diagnoses and treatment monitoring. Founded by biomedical engineer Dr. Ángel Alberich-Bayarri and radiologist Prof. Luis Martí-Bonmatí, the company has developed a cloud-based platform called Quibim Precision that uses radiomics and AI to extract disease-specific biomarkers invisible to the human eye. Their solutions span oncology, neurology, and immunology, with FDA-cleared products like QP-Prostate for prostate cancer detection. The company recently raised a $50M Series A round in January 2025, bringing total funding to €60.9M, and is used across more than 180 sites worldwide including leading hospitals and pharmaceutical companies.